Stocks to buy: Choice Broking sees 20% upside in this healthcare stock. Should you buy?

Choice Institutional Equities has reiterated a BUY rating on Park Medi World Ltd with a target price of around 350, implying an upside of about 20.6% from the current market price of around 290. The brokerage highlighted the hospital chain's aggressive capacity expansion targeting 5,590 beds by March 2028 and a long-term aspiration of 10,000 beds by FY33, alongside new facilities in Gurugram and a 330-bed acquisition in Rudrapur. Choice projects revenue to grow from 16.8 billion rupees in FY26 to 39.4 billion rupees by FY29; the stock, listed in December 2025, has risen about 79% from its issue price of 162 rupees.